Market Currents
Neurocrine Biosciences (NBIX +2%) gets a lift after being initiated with a Buy at Roth Capital...
-
Wednesday, June 20, 2012, 10:45 AM ETNeurocrine Biosciences (NBIX +2%) gets a lift after being initiated with a Buy at Roth Capital with a price target of $14.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
